[ad_1] The logo of Swiss pharmaceutical group Lonza is seen at its headquarters in Basel, Switzerland March 2, 2020. REUTERS/Arnd Wiegmann (Reuters) – Moderna Inc and Swiss contract drugmaker Lonza…
Tag: Pharmaceuticals & Medical Research (TRBC level 2)
Swiss boost COVID-19 vaccine reservations with shots from Pfizer, WHO-led programme
[ad_1] FILE PHOTO: Small bottles labelled with “Vaccine” stickers stand near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File…
UPDATE 1-Italy ready to raise 2021 deficit to support businesses through Covid-19 – PM
[ad_1] (Adds quote, context) MILAN, Nov 11 (Reuters) – Italy’s government is ready to increase its 2021 budget deficit and review this year’s to fund further compensation for businesses hit…
Factbox: Moderna’s mRNA coronavirus vaccine
[ad_1] (Reuters) – Moderna Inc became the second U.S company to release full results from a large study of its experimental vaccine, saying it was 94.1% effective against COVID-19. FILE…
Activist investor Acacia buys stake in UK-listed Sensyne Health
[ad_1] LONDON (Reuters) – New York-based Acacia Research Corporation said on Tuesday it had acquired an 11.8% stake in UK-listed artificial intelligence healthcare company Sensyne Health SENSS.L. Acacia which earlier…
Swiss stocks – Factors to watch on June 30
[ad_1] ZURICH, June 30 (Reuters) – The Swiss blue-chip SMI was seen opening 0.2 percent higher at 7,992 points on Thursday, according to premarket indications by bank Julius Baer .…
Amazon, pharma firms should help COVID-19 vaccine reach poorest: German minister
[ad_1] FILE PHOTO: German Economic Cooperation and Development Minister Gerd Mueller attends the weekly cabinet meeting at the Chancellery in Berlin, Germany September 16, 2020. Michael Sohn/Pool via REUTERS BERLIN…